Find therapies in clinical trials near you – page 484

Study on Ublituximab for Patients with Relapsing Multiple Sclerosis

Study on Ublituximab for Patients with Relapsing Multiple Sclerosis

Study of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease

Study of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease

Bioavailability Study of Lidocaine Vitamin C Lozenge (drug combination) in Healthy Volunteers

Phase 1 Safety and Tolerability of Oral VENT-02 in Healthy Volunteers for Neuroinflammatory and Neurodegenerative Diseases

Phase 1b Study of CC-90010 with Temozolomide in Adults with Newly Diagnosed Glioblastoma After Surgery

Phase 1b Study of CC-90010 with Temozolomide in Adults with Newly Diagnosed Glioblastoma After Surgery

Bioavailability of ibuprofen 2% and 4% oral suspensions compared with standard ibuprofen oral suspension in healthy adult males and females

Evaluation of Tirzepatide Versus Placebo in Adolescents with Obesity or Overweight and Weight-Related Comorbidities: A Randomized, Double-Blind Clinical Trial

Evaluation of Tirzepatide Versus Placebo in Adolescents with Obesity or Overweight and Weight-Related Comorbidities: A Randomized, Double-Blind Clinical Trial

Efficacy and Safety of Tirzepatide Versus Placebo in Adults with Type 1 Diabetes and Obesity or Overweight: A Phase 3 Randomized Controlled Trial

Efficacy and Safety of Tirzepatide Versus Placebo in Adults with Type 1 Diabetes and Obesity or Overweight: A Phase 3 Randomized Controlled Trial

Evaluation of topical clascoterone versus drug combination for skin vasoconstriction in healthy volunteers

Evaluation of topical clascoterone versus drug combination for skin vasoconstriction in healthy volunteers

Drug interaction study of leniolisib with a drug combination in healthy volunteers for Activated PI3K Delta Syndrome

Drug interaction study of leniolisib with a drug combination in healthy volunteers for Activated PI3K Delta Syndrome

Comparing Two Oral Doses of macitentan (10 mg vs 75 mg) in Healthy Participants for Pulmonary Arterial Hypertension

Comparing Two Oral Doses of macitentan (10 mg vs 75 mg) in Healthy Participants for Pulmonary Arterial Hypertension

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk